B cells, plasma cells and antibody repertoires in the tumour microenvironment

GV Sharonov, EO Serebrovskaya… - Nature Reviews …, 2020 - nature.com
Recent data show that B cells and plasma cells located in tumours or in tumour-draining
lymph nodes can have important roles in shaping antitumour immune responses. In tumour …

MUC1: a multifaceted oncoprotein with a key role in cancer progression

S Nath, P Mukherjee - Trends in molecular medicine, 2014 - cell.com
The transmembrane glycoprotein Mucin 1 (MUC1) is aberrantly glycosylated and
overexpressed in a variety of epithelial cancers, and plays a crucial role in progression of …

Sialic acids in cancer biology and immunity

OMT Pearce, H Läubli - Glycobiology, 2016 - academic.oup.com
During malignant transformation, glycosylation is heavily altered compared with healthy
tissue due to differential expression of glycosyltransferases, glycosidases and …

[HTML][HTML] CAR-T cell therapy for breast cancer: from basic research to clinical application

YH Yang, JW Liu, C Lu, JF Wei - International journal of biological …, 2022 - ncbi.nlm.nih.gov
Breast cancer rises as the most commonly diagnosed cancer in 2020. Among women,
breast cancer ranks first in both cancer incidence rate and mortality. Treatment resistance …

Mucins: a biologically relevant glycan barrier in mucosal protection

AP Corfield - Biochimica et Biophysica Acta (BBA)-General Subjects, 2015 - Elsevier
Background The mucins found as components of mucus gel layers at mucosal surfaces
throughout the body play roles in protection as part of the defensive barrier on an organ and …

Cell surface protein glycosylation in cancer

MN Christiansen, J Chik, L Lee, M Anugraham… - …, 2014 - Wiley Online Library
Glycosylation of proteins is one of the most important PTMs, with more than half of all human
proteins estimated to be glycosylated. It is widely known that aberrant glycosylation has …

Altered tumor-cell glycosylation promotes metastasis

I Häuselmann, L Borsig - Frontiers in oncology, 2014 - frontiersin.org
Malignant transformation of cells is associated with aberrant glycosylation presented on the
cell-surface. Commonly observed changes in glycan structures during malignancy …

CAR T cells targeting the tumor MUC1 glycoprotein reduce triple-negative breast cancer growth

R Zhou, M Yazdanifar, LD Roy, LM Whilding… - Frontiers in …, 2019 - frontiersin.org
Antibody-derived chimeric antigen receptor (CAR) T cell therapy has achieved gratifying
breakthrough in hematologic malignancies but has shown limited success in solid tumor …

Nucleic acid aptamers: clinical applications and promising new horizons

X Ni, M Castanares, A Mukherjee… - Current medicinal …, 2011 - ingentaconnect.com
Aptamers are a special class of nucleic acid molecules that are beginning to be investigated
for clinical use. These small RNA/DNA molecules can form secondary and tertiary structures …

Simple sugars to complex disease—mucin-type O-glycans in cancer

MR Kudelka, T Ju, J Heimburg-Molinaro… - Advances in cancer …, 2015 - Elsevier
Mucin-type O-glycans are a class of glycans initiated with N-acetylgalactosamine (GalNAc) α-
linked primarily to Ser/Thr residues within glycoproteins and often extended or branched by …